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Abstract
We study a diagnostic strategy which is based on the anticipation of the diagnostic process
by simulation of the dynamical process starting from the initial findings. We show that such a
strategy could result in more accurate diagnoses compared to a strategy that is solely based on
the direct implications of the initial observations. We demonstrate this by employing the mean-
field approximation of statistical physics to compute the posterior disease probabilities for a given
subset of observed signs (symptoms) in a probabilistic model of signs and diseases. A Monte
Carlo optimization algorithm is then used to maximize an objective function of the sequence
of observations, which favors the more decisive observations resulting in more polarized disease
probabilities. We see how the observed signs change the nature of the macroscopic (Gibbs) states
of the sign and disease probability distributions. The structure of these macroscopic states in the
configuration space of the variables affects the quality of any approximate inference algorithm (so
the diagnostic performance) which tries to estimate the sign/disease marginal probabilities. In
particular, we find that the simulation (or extrapolation) of the diagnostic process is helpful when
the disease landscape is not trivial and the system undergoes a phase transition to an ordered
phase.
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I. INTRODUCTION
Statistical physics has been widely used to extract macroscopic properties of a wide range
of systems from their microscopic interaction models, yet it has not been employed to medical
diagnostics. Given an initial subset of observed signs (symptoms, clinical and laboratory
findings) with some prior knowledge about the patient (or a complex system like a biological
cell), a diagnosis problem simply asks for the most probable diseases (or macrostates with
specific phenotypes) [1–3]. An efficient and accurate diagnostic procedure is important
specially in the early stages of diseases, where the number and quality of medical evidences
are often insufficient to reach a definite diagnosis. Here, we use approximate inference and
optimization algorithms of statistical physics [4, 5] to show that a simulation (extrapolation)
of the diagnostic process (without doing any real observation) could be helpful as a heuristic
strategy in the study of diagnosis problems.
A diagnosis problem usually starts with a (probabilistic) model of (well-defined) sign
and disease variables which describes the (statistical) dependencies of the variables; such
an “effective” model of the signs and diseases may come from a microscopic model of the
system (human body or biological cell) with emergent macroscopic behaviors that are inter-
preted as diseases. Various modeling frameworks have been developed and used in medical
diagnostics: (i) probabilistic models and belief networks, (ii) neural networks and machine
learning methods, and (iii) a complex network approach to the problem.
Bayesian belief networks provide a probabilistic framework to study the sign-disease de-
pendencies [6–10]. The belief networks are represented by tables of conditional probabilities
that show how the state of a variable in an acyclic directed graph depends on the state of the
parent variables. The above information along with a few simplifying assumptions then are
used to infer the marginal sign and disease probabilities for a given set of findings [7]. An-
other approach is to use an artificial neural network to represent the complex relationships
of the sign/disease variables [11–13]. The model parameters here are obtained in a learning
process using the machine learning techniques [14]. Finally, in a network approach to the
problem, one constructs a (weighted) symptom-disease network with connections relating
the signs to the diseases. This network along with other complementary data, e.g., gene-
disease, RNA-disease, protein-disease, metabolite-disease and disease-disease networks, are
then utilized as information resources by a diagnostic algorithm [15–20].
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In addition to the model, an efficient inference algorithm is needed to estimate the
marginal sign and disease probabilities [21, 22]. When the number of initially observed
signs is too small to make a diagnosis, we need to suggest a number of new medical tests
to know the value of several other relevant signs. For this aim, we need an appropriate
objective function and optimization algorithm to choose the more informative signs, which
can lead us to the right diagnosis with a smaller number of observations. In Refs. [23, 24] we
proposed probabilistic models of signs and diseases which can systematically take into ac-
count the effects of different types of sign-disease, disease-disease, and sign-sign interactions;
the models are indeed graphical models of the sign and disease variables with a number of
interaction factors, each one connecting a small subset of disease variables to the associated
sign variables [22]. We introduced approximate inference and optimization algorithms to
deal with such probabilistic models, and studied the effects of the model structure and the
objective function on the performances of the diagnostic algorithms.
The models we consider are natural generalizations of the simpler probabilistic models
studied in previous works [7, 8, 10], which usually assume that only one disease is behind
the findings (exclusive diseases assumption), or, the diseases act independently on the signs
(causal independence assumption). Moreover, for computational simplicity, it is usually
assumed that there is no disease-disease and sign-sign interactions. In Ref. [23], we showed
that such interactions can significantly improve the accuracy of diagnosis without resorting
to the exclusive diseases or the causal independence assumption.
In this paper, we elaborate more on the nature and behavior of the macroscopic states
of the probabilistic models we introduced in the above studies. We employ the mean-field
approximation to study the possible changes in the (macroscopic) state of the system as the
number of observed signs increases, and to estimate the sign and disease marginal probabil-
ities [25]. For the objective function, we choose a function that favors the more polarizing
tests, which result in disease probabilities that are closer to zero or one [23]. This could be
useful especially when the gap between the most probable diseases and the other diseases
is small. Moreover, this objective function is easier to compute than a maximum-likelihood
function that is typically taken in these problems. Starting from an initial set of observed
signs, we use an approximate (Monte Carlo) optimization algorithm to find a sequence of
candidate observations that maximizes the above objective function [24]. However, instead
of the true value of the “observed” sign at each step, we assume the outcome is given by
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the most probable value of the sign obtained from the model by the approximate inference
algorithm. We show that this strategy is able to improve the quality of diagnosis compared
to the case that is merely based on the direct implications of the initial findings. Interest-
ingly, the improvement is observed for nontrivial cases when the system undergoes a phase
transition to an ordered phase; i.e., where the effect of observed signs can propagate in the
system to influence the state of the other signs (for a similar phenomenon see [26]).
II. MAIN DEFINITIONS
The microscopic state of the system (patient or cell) is identified by the sign values
S = {Si : i = 1, . . . , NS}, where for simplicity we work with binary sings Si = ±1. The
probability of being in state S is given by P (S). The probability P (S) (the model) is
parametrized by a set of couplings K(t), which in general depend on real time t. The
conditional probability of the unobserved signs depends on the subset of the observed signs
O(t) = {j = 1 . . . , NO(t)} with the values denoted by S
o(t) = {Sj : j ∈ O(t)}.
The macroscopic states (or phenotypes, or diseases) of the system (for large number
of signs NS → ∞) can be identified by the Gibbs states of P (S) [27]. We label these
macroscopic states with D, for diseases, with D = 0 representing the healthy state. The
average of an unobserved sign in state D is denoted by 〈Si〉D. A pure Gibbs state is
characterized by the clustering property; i.e., 〈SiSj〉D − 〈Si〉D〈Sj〉D goes exponentially to
zero by the distance of sign nodes i and j in the interaction graph of the sign variables
induced by P (S). A mixed state is composed of more than one pure states. In this way, the
state of a disease pattern D or a cluster of similar disease patterns are represented by the
statistical properties of the sign variables in the associated pure or mixed Gibbs states.
We start by asking several interesting questions:
• What is P (S) and how does it (or the couplings K) change with time? Here we
need a dynamical model of the system to study the stochastic evolution of the sign
variables. In the following, we shall assume some reasonable structures for the model
and leave this problem for future studies. Instead of going from the model P (S) to
the macroscopic states, we start from the diseases D and obtain the model from the
joint probability of the sign and disease variables P (S;D) = P (S|D)P0(D). Then, the
model is obtained by summing over the disease variables P (S) =
∑
D P (S|D)P0(D).
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The conditional probability P (S|D) can be a decreasing function of the distance of S
and a reference sign configuration S(D). Here the Si(D) represent the most probable
symptoms of disease D. These models could be useful (in the absence of the realistic
models) as benchmarks in the study of a diagnosis problem.
• Do we see a significant change of behavior with time in P (S)? For example, from weak
sign correlations to a regime of strong correlations. Typically, we encounter strong
correlations close to a phase transition from one macroscopic state to another state.
As we will see, even simple (but plausible) models of signs and diseases can exhibit
both continuous and discontinuous phase transitions as the strength of the sign and
disease interactions are varied. In particular, the phase transition can be induced by
increasing the number of observed signs for given strength of the interactions.
• How does the structure of P (S) affect the diagnosis? Here we need an efficient and
approximate inference algorithm to compute the sign and disease probabilities. It
is easy to obtain very good estimations of these marginal probabilities as long as
there is only one macroscopic (pure) state, or there are a number of symmetry-related
states. Otherwise, the above algorithms will not converge or will need a very large
computation time to provide a fair sampling of the probability distribution. We will
see how the convergence and quality of an approximate inference algorithm which is
based on the mean-field approximation affect the diagnostic performance.
Consider a set of ND binary variables D = {Da = 0, 1 : a = 1, . . . , ND}, where Da = 0, 1
shows the absence or presence of disease a. Each disease is assigned a positive weight Wa,
to take into account the significance of diseases. In the following we assume the Wa are
uniformly distributed in (0, 1). The joint probability distribution of the sign and disease
variables (i.e., the model) is identified by P (S;D) = P (S|D)P0(D). Here P0(D) is the prior
probability distribution of diseases, which could depend on the patient’s characteristics such
as gender and age and disease properties such as duration of a disease, mortality rate and
transmission rate among others. In the following, we shall assume the prior probability is
factorized as P0(D) ∝ exp(
∑
aK
0
aDa). The parameters K
0
a can also be used to control the
expected number of present diseases.
Let Ptrue(S|D) to be the true (or empirically estimated) probability distribution of the
sign variables given the disease hypothesis D. In practice, we may have access only to a
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small subset of marginal probabilities of the above probability distribution. For instance,
suppose we are given the sign probabilities Ptrue(Si|nodisease), Ptrue(Si, Sj|onlyDa), and
Ptrue(Si, Sj|onlyDa, Db) conditioned on the presence of no diseases, the presence of only one
disease, and the presence of only two diseases, respectively. Using the maximum entropy
principle, for the conditional probability distribution of the signs we take
P (S|D) =
1
Z(D)
φ0(S)×
∏
a
φa(S|Da)×
∏
a<b
φab(S|Da, Db), (1)
where the partition function Z(D) is obtained from normalization.
The disease interaction factors (φ0, φa, φab) can in general be parametrized by the cou-
plings of all the possible multi-sign interactions. As customary in maximum entropy model-
ing, assuming an exponential family, the parameters sufficient to describe the above marginal
probabilities are involved in the one-sign terms (K0i Si), the one-disease-one-sign interactions
(Kai DaSi), the one-disease-two-sign interactions (K
a
ijDaSiSj), the two-disease-one-sign in-
teractions (Kabi DaDbSi), and finally the two-disease-two-sign interactions (K
ab
ij DaDbSiSj).
More precisely, the disease interaction factors are given by
φ0(S) = e
∑
iK
0
i Si, (2)
φa(S|Da) = e
Da[
∑
iK
a
i Si+
∑
i<j K
a
ijSiSj ], (3)
φab(S|Da, Db) = e
DaDb[
∑
iK
ab
i Si+
∑
i<j K
ab
ij SiSj ]. (4)
Figure 1 shows the interaction graph of the sign and disease variables related by the above
interaction factors. We use Ma, ka and Mab, kab for the number and connectivity of one-
disease and two-disease interaction factors, respectively.
In principle, the information provided by the marginal probabilities of the true (or empir-
ical) probability distribution is sufficient to determine the model parameters [28–31]. Note
that φ0(S) is responsible for the probability of observing S in the absence of any diseases,
where the most probable value is Si = −1. It is reasonable to assume that in the healthy
case each sign takes the positive value with a small probability independently of the other
sign values.
The joint probability distribution of the sign and disease variables can be rewritten as,
P (S;D) ∝ exp(−H(S;D)), where the energy function reads as follows
H(S;D) = −
∑
i
hi(D)Si −
∑
i<j
Jij(D)SiSj + lnZ(D)− lnP0(D). (5)
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Here, the partition function and the new couplings are:
Z(D) =
∑
S
e
∑
i hi(D)Si+
∑
i<j Jij(D)SiSj , (6)
hi(D) = K
0
i +
∑
a
KaiDa +
∑
a<b
Kabi DaDb, (7)
Jij(D) =
∑
a
KaijDa +
∑
a<b
Kabij DaDb. (8)
From the above model, we can extract simpler models depending one the maximum number
of disease and sign variables that are involved in the interactions; for instance, we could have
the D1S1 (one-disease-one-sign), D1S2 (one-disease-two-sign), D2S1 (two-disease-one-sign),
and D2S2 (two-disease-two-sign) models.
In the following, we consider only the D1S1 and D2S1 models, where we can exactly
compute the partition function Z(D) =
∏
i (2 cosh hi(D)). For these models, we can also
exactly compute the model parameters given the true marginal probabilities,
K0i =
1
2
ln
(
Ptrue(Si = +1|nodisease)
Ptrue(Si = −1|nodisease)
)
, (9)
Kai =
1
2
ln
(
Ptrue(Si = +1|onlyDa)
Ptrue(Si = −1|onlyDa)
)
−K0i , (10)
Kabi =
1
2
ln
(
Ptrue(Si = +1|onlyDa, Db)
Ptrue(Si = −1|onlyDa, Db)
)
−K0i −K
a
i −K
b
i . (11)
For a given subset O of observed signs with values So, the disease probabilities are
obtained from
P (Da = 1|S
o) =
1
Z(So)
∑
D
Dae
−H(D|So), (12)
where H(D|So) = − logL(D|So) is the log-likelihood function
H(D|So) = −
∑
a
K0aDa −
∑
i∈O
Soi hi(D) +
∑
i∈O
ln (2 cosh hi(D)) , (13)
and Z(So) =
∑
D exp(−H(D|S
o)) is another normalization constant. As before, the prior
probability distribution is P0(D) ∝ exp(
∑
aK
0
aDa). It is easy to show that the marginal
probability of an unobserved sign is given by:
P (Si = 1|S
o) =
1
Z(So)
∑
D
(
1 + tanhhi(D)
2
)
e−H(D|S
o). (14)
The approximate equations for the D1S2 and D2S2 models can be found in [23].
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III. THE HOMOGENEOUS FULLY-CONNECTED MODELS
The direct problem of inferring the marginal sign/disease probabilities from the above
models can be solved exactly as long as the model parameters do not depend on the sign
or disease labels. The thermodynamic limit here is defined by the limit ND, NS, NO → ∞
such that γ = ND/NS and no = NO/NS remain finite. To provide some order of magnitude,
it is useful to mention that in Internist (a probabilistic model for internal diseases [7]) the
number of diseases is about 500 and the number of associated signs is around 4000. In
addition, we need to scale the model parameters as Kaij = κ
a
ij/(NSND), K
ab
ij = κ
ab
ij /(NSN
2
D),
K0i = κ
0
i , K
a
i = κ
a
i /ND, K
ab
i = κ
ab
i /N
2
D, and K
0
a = κ
0
a; the scaling ensures that the energy
function is extensive (proportional to NS).
The sign and disease probabilities are obtained by minimizing the following free energy
with respect to x = P (D = 1) and yu = P (S = 1) (for an unobserved sign),
f(x, y) = −γS(x) − (1− no)S(
1 + yu
2
) + S(
1 + z(x)
2
)
− h(x)(y − z(x))−
1
2
J(x)(y2 − z2(x))− γκ0ax. (15)
The value of the observed signs enters in y = noyo + (1 − no)yu with yo = (
∑
i∈O S
o
i )/NO,
and yu = (
∑
i/∈O Si)/(NS − NO). Here z is the solution to z = tanh(h(x) + J(x)z), and
S(x) = −x log x− (1− x) log(1− x) is the Gibbs-Shannon entropy function. Moreover, the
effective field h(x) = κ0i +κ
a
i x+
1
2
κabi x
2 and the coupling J(x) = κaijx+
1
2
κabij x
2 (see Appendix
A for the derivations). Each local or global minimum of the free energy can be considered
as a macroscopic state of the system. Figure 2 shows how the sign and disease probabilities
change with the number of observations, when all the observed signs have a positive value
(see also Fig. 7 in Appendix A). As the figures show, a new macroscopic state can appear
continuously or discontinuously depending on the value of the model parameters.
IV. THE INHOMOGENEOUS MODELS: MEAN-FIELD APPROXIMATION
In this section, we find an estimation of the sign and disease probabilities for arbitrary
couplings K. To this end, we write Da = 〈Da〉 + δDa and Si = 〈Si〉 + δSi where the
δDa = Da−〈Da〉 and δSi = Si−〈Si〉 are small deviations from the mean values. The mean-
field (MF) approximation here is obtained by neglecting the second order deviations in a
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Taylor expansion around the mean values [25]. In the following, we shall restrict ourselves
to the D1S1 and D2S1 models, where the normalization function Z(D) can be computed
exactly; for the D1S2 and D2S2 models we need also to compute this function within the
MF approximation (see Appendix B).
In this way, the MF approximation for the sign and disease probabilities are obtained by
solving the self-consistency equations xa = exp(ha(x))/(1 + exp(ha(x))), with P (Da = 1) =
xa and P (Si = 1) = (1 + tanh hi(x))/2. Here, the effective fields experienced by the sign
and disease variables are given by
hi(x) = K
0
i +
∑
a
Kai xa +
∑
a<b
Kabi xaxb, (16)
ha(x) = K
0
a +
∑
i∈O
[Soi − tanh(hi(x))](K
a
i +
∑
b6=a
Kabi xb). (17)
The equations are solved by iteration starting from random initial values for the xa. The
time complexity of this algorithm is of order NON
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D in a fully-connected model. The fixed
points of these equations are considered as the macroscopic states of the system (Gibbs
states). As long as there is only one macroscopic state, the iteration algorithm converges
easily to the single fixed point of the equations. Non-convergence of the iteration algorithm
is a signature of the presence of more than one fixed point.
To check the performances of the algorithms, we shall assume that the true model is given
by an exponential probability distribution Ptrue(S|D) ∝ exp(−βH(S;S(D))). Here S(D)
gives the most probable symptoms of disease pattern D, and H(S;S(D)) is the Hamming
distance (number of different elements) of the two sign configurations. Moreover, β is a
positive parameter that controls the structure of the true model around the symptoms
S(D); the diseases are more clearly distinguished for larger values of β. We assume that
each element Si(D) (for i = 1 . . . , NS) takes the positive and negative values with equal
probability, except for the healthy case (D = 0) where all the elements are negative. Given
the true model, we use the true marginal probabilities to construct e.g. the D2S1 model.
Suppose that we are given a subset O of NO observed signs with values S
o. A simple
diagnostic procedure works by computing the posterior disease probabilities conditioned
on the observations P (Da|S
o). Then, the most probable diseases or those that have a
probability greater than a threshold value, are reported as the diagnosed diseases; in the
following, we shall assume that the most probable diseases, within a small window of size
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δPD = 0.01, are the present ones. Figure 3 displays the accuracy of such a diagnosis with
the D1S1 and D2S1 models for a small number of sign and disease variables. The figure
also shows the probability gap between the most probable disease(s) and the other diseases.
A patient with disease pattern D and NO initial observed signs from the most probable
symptoms S(D) is presented to the model for diagnosis; a disease pattern is chosen with
a probability proportional to the weights Wa of the present diseases in D. From [23] we
know that the D1S1 and D2S1 models work well so long as the number of present diseases
in D, denoted by |D|, is less than or equal to two; that is why we choose patients with a
small number of diseases. As the figure shows, we obtain more accurate predictions as the
parameter β increases. The situation is different when we have to resort to an approximate
inference algorithm. We see in Fig. 4 that the MF approximation does not provide accurate
estimations of the sign and disease marginal probabilities for large β, where the algorithm
does not converge. Here the best performances are observed for intermediate values of β.
V. DIAGNOSIS BY SIMULATION OF THE DIAGNOSTIC PROCESS
It may happen that the information provided by the initial number of observations are
not enough to reach a reliable diagnosis, especially in the early stages of the diseases. Thus,
we need a good strategy to choose the most informative signs for the next observations.
Here the goal could be to reach the right diagnosis with a minimum number of the medical
tests [23, 24]. Thus, for the objective function we propose an increasing function of the
polarizations (deviations from the neutral value) in the posterior disease probabilities. The
optimal choice then is provided by the most polarizing observation conditioned on the value
of the previous observations. In contrary to the maximum likelihood function which is
computationally hard to compute, the above objective function can easily be computed
given the posterior disease probabilities. And, one can easily incorporate the importances
of the diseases (the Wa) into the objective function, to assign more weight to polarization
of the more important diseases.
In a sequential diagnostic process of length T , we do the medical tests one by one and
at each step we obtain the true value of the observed sign (this is called Diags-I in [24]).
To obtain an optimal sequence of medical tests, one has to simulate in advance a diagnostic
process of T observations without doing any real observation (this is called Diags-II in
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[24]). This simulation of the observation process, or extrapolation from the initial set of
observations, is proposed here as another heuristic approach to diagnosis to fully exploit
the statistical dependencies of the variables provided by the model in addition to the initial
medical tests. To this end, we use the mean-field approximation to compute the posterior
disease probabilities. Then, the (Monte Carlo) optimization algorithm of Ref. [24] is used
to maximize an objective functional of T observations,
E [O(T )] =
T∑
t=1
(
1∑
aWa
∑
a
Wa
∣∣∣∣P (Da = 1)− 12
∣∣∣∣
)
. (18)
Here O(T ) = {j1, . . . , jT} is the sequence of observations. One can also add the cost or
relevance of the observed signs to this objective function [24]. The optimization algorithm
starts from a random sequence of T observations, uses the marginal sign probabilities to
generate a sequence of new observations, and accepts the suggested sequence if the objective
function increases.
Note that the above problem is indeed a stochastic optimization problem, where the
objective function depends on the stochastic outcomes of the observations [32, 33]. To
simplify the computation, we assume that the observed sign j at each time step takes the
most probable value identified by the marginal probability P (Sj|S
o) conditioned on the value
of the previous observed signs.
Figure 5 shows how the above objective function and the optimization algorithm perform.
The figure displays the changes the first right and wrong diagnosis times compared to a
random sequence of T observations [24]; the first right diagnosis time TR is the first time
(number of observations) the probability of having a right disease becomes larger than a
threshold value, here Pth = 0.9. Similarly we define the first wrong diagnosis time TW .
In Fig. 6, we compare the accuracy of the diagnosis with the D2S1 model before and
after extrapolation for T = NO/2 steps. Here the sign/disease marginal probabilities are
computed by the MF approximation. Similar comparisons are shown also in Figs. 3 and 4.
VI. DISCUSSION
In summary, depending on the model and the strength of the model parameters, new
macroscopic states can appear as the number of observed signs increases. This could be
helpful because the disease probabilities are usually more informative within such states. On
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the other hand, this affects the algorithm convergence and consequently the quality of the
sign and disease probabilities which are computed by the approximate inference algorithm.
More advanced and accurate algorithms can of course improve the quality of inference, but
at the expense of more computational time [23].
We showed that simulation of the diagnostic process provides a useful strategy for diag-
nosis when a naive approach that is based on the direct implications of the observed signs
is not very helpful. In other words, this strategy works in the ordered phase of the system
where the values of the observed signs significantly affect the probability distribution of the
unobserved signs; the classical example is a ferromagnetic spin system in the ordered (low
temperature) phase where the values of the boundary spins determine the physical (Gibbs)
state of the system. In this way, we can define a critical number of initial observations which
are needed to enter such an ordered state, for systems that display a phase transition.
Here, for the sake of efficiency, we assumed that each ”observed” sign in the simulation
takes the most probable value predicted by the model. Moreover, we used a very naive
optimization algorithm to find the optimal sequence of observations. A more accurate study
should consider the stochastic nature of the simulated observations, and employ a more
sophisticated optimization algorithm, e.g., simulated annealing. Finally, it would be inter-
esting to have a microscopic (or phenomenological) model of patient (or an ensemble of
patients) to study the time evolution of the sign probability distribution, and the emergent
macroscopic (disease) states.
VII. PERSPECTIVES
An accurate medical diagnosis from a limited number of findings (e.g. at the early stages
of diseases) should exploit all the statistical information on the sign/disease dependencies
observed in the clinical and laboratory data. Such interdependencies are emerging due to the
advancements in omics technologies and progress in population studies and aging research
(e.g. identification of co-occurrence of age-related diseases). We note that the existing
datasets lack the necessary probabilistic information needed for our approach, as such new
data need to be generated. These studies will be the subject of our future works and in
the current article, we are primarily addressing the mathematics and statistical physics
communities.
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Let us recall briefly the kind of statistical data we need to construct the models studied in
this paper. First, note that these models have been obtained from an expansion around the
healthy state where the number of involved diseases is small (|D| = 1, 2) [23]. On the other
hand, given a disease hypothesis D, it is usually assumed that the sign variables are uncor-
related in a zero-order approximation of the signs statistics [7]. Here, the necessary data are
encoded in the conditional probabilities P (Si|onlyDa) (in D1S1 model) or P (Si|onlyDa, Db)
(in D2S1 model). Obviously, we expect to have two-sign correlations, or higher-order sign
correlations, even in presence of only a single disease. But taking into account these corre-
lations considerably increases the computational complexity of the problem. Additionally,
it is in practice very difficult to obtain statistically good clinical data which capture the
higher-order correlations. Nevertheless, in the end, it is the collection of available empirical
data that determines the structure of the model.
The method can in principle be applied to any diagnostic problem to infer the macro-
scopic state (phenotype) of the system from a limited number of evidences. This could be,
for instance, the problem of assigning a state to a biological cell or a complex electronic
device. In particular, assignment of state to a cell is a major challenge in immunology and
cancer biology and it has complicated developing therapies for cancer and autoimmunity.
We envision that our approach will be generically applied to a wide range of problems in
medicine, science and technology.
Appendix A: The homogeneous fully-connected models
As long as the model parameters do not change with the sign or disease labels, we
can write all the quantities in terms of the collective variables x = (
∑
aDa)/ND and y =
(
∑
i Si)/NS. Then for large number of signs (NS →∞), we get
1
NS
lnZ(D) ≈ S(
1 + z(x)
2
) + h(x)z(x) +
1
2
J(x)z2(x), (A1)
1
NS
H(S;D) ≈ −h(x)(y − z(x))−
1
2
J(x)(y2 − z2(x)) + S(
1 + z(x)
2
)− γκ0ax, (A2)
where γ = ND/NS, and
h(x) = κ0i + κ
a
i x+
1
2
κabi x
2, (A3)
J(x) = κaijx+
1
2
κabij x
2. (A4)
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Here we take the scaling
K0i = κ
0
i , K
0
a = κ
0
a, (A5)
Kai =
1
ND
κai , K
ab
i =
1
N2D
κabi , (A6)
Kaij =
1
NSND
κaij, K
ab
ij =
1
NSN2D
κabij . (A7)
Moreover, z is the solution to
z = tanh(h(x) + J(x)z). (A8)
which minimizes the following free energy
f(z) = −S(
1 + z
2
)− h(x)z −
1
2
J(x)z2, (A9)
Here, for brevity, we defined the Shanon entropy function
S(p) = −p ln p− (1− p) ln(1− p). (A10)
To take into account the value of the observed signs, we write y = noyo+ (1−no)yu with
yo = (
∑
i∈O S
o
i )/NO, yu = (
∑
i/∈O Si)/(NS − NO), and no = NO/NS. In this way, the grand
partition function is given by
Z(So) ≃
∫ 1
0
dx
∫ 1
−1
dyue
−NSf(x,y), (A11)
At the end, the self-consistency equations for the x and yu variables in the thermodynamic
limit (NS →∞), are obtained by minimizing the following free energy
f(x, y) = −γS(x) − (1− no)S(
1 + yu
2
)
− h(x)(y − z(x)) −
1
2
J(x)(y2 − z2(x)) + S(
1 + z(x)
2
)− γκ0ax. (A12)
Figure 7 shows how the above free energy behaves when the model parameters in the D2S1
model are varied.
Appendix B: The inhomegeuous models: mean-field approximation
For the D1S1 and D2S1 models we can compute some quantities exactly, therefore, we
present the mean-field approximation for these models separately.
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1. In the absence of the sign-sign interactions
Here we write Da = xa + δDa where xa = 〈Da〉, and δDa = Da − xa is a small deviation
from the mean value. Then, the local field experienced by sign i is
hi(D) = hi(x) +
∑
a
Kai δDa +
∑
a<b
Kabi (δDaxb + xaδDb + δDaδDb) = hi(x) + δhi, (B1)
where
hi(x) = K
0
i +
∑
a
Kai xa +
∑
a<b
Kabi xaxb. (B2)
The Hamiltonian can be written as
H(D|So) = −
∑
a
K0aDa −
∑
i∈O
Soi [hi(x) + δhi] +
∑
i∈O
ln (2 cosh[hi(x) + δhi]) , (B3)
Expanding the last term up to the first order deviations δDa, we get
H(D|So) ≈ H0 −
∑
a
ha(x)Da, (B4)
with
ha(x) = K
0
a +
∑
i∈O
[Soi − tanh(hi(x))](K
a
i +
∑
b6=a
Kabi xb). (B5)
Then, the average values xa are obtained by the following self-consistency equations:
xa =
eha(x)
1 + eha(x)
, (B6)
The equations are solved by iteration starting from random initial values for the xa.
2. In the presence of the sign-sign interactions
In general, the partition function in the MF approximation reads
Z(D) ∝
∏
i
(
2 cosh[hi(D) +
∑
j 6=i
Jij(D)zj(D)]
)
, (B7)
where the zi are solutions to
zi(D) = tanh[hi(D) +
∑
j 6=i
Jij(D)zj(D)]. (B8)
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Define δDa = Da − 〈Da〉 and δSi = Si− 〈Si〉. For brevity, we take xa = 〈Da〉 and yi = 〈Si〉.
Note that yi = S
o
i is fixed for i ∈ O (the subset of observed signs).
Then, to first order in the δDa and δSi, we have
H(S;D) ≈ H0 −
∑
i/∈O
[hi(x) +
∑
j 6=i
Jij(x)yj ]Si −
∑
a
ha(x,y, z)Da, (B9)
where
ha(x,y, z) = K
0
a +
∑
i
Bai (x)yi +
∑
i<j
Baij(x)yiyj
−
∑
i
tanh[hi(x) +
∑
j 6=i
Jij(x)zj]×
(
Bai (x) +
∑
j 6=i
[Baij(x)zj + Jij(x)χ
a
j ]
)
(B10)
Here, the new introduced local fields are
Bai (x) = K
a
i +
∑
b6=a
Kabi xb, (B11)
Baij(x) = K
a
ij +
∑
b6=a
Kabij xb, (B12)
and the susceptibility χai is given by
χai =
∂zi
∂xa
= (1 + tanh2[hi(x) +
∑
j 6=i
Jij(x)zj ])
×
(
Bai (x) +
∑
j 6=i
[Baij(x)zj + Jij(x)χ
a
j ]
)
. (B13)
In summary, the mean-field equations read as follows,
xa =
eha(x,y,z)
1 + eha(x,y,z)
, (B14)
yi = S
o
i , i ∈ O (B15)
yi = tanh[hi(x) +
∑
j 6=i
Jij(x)yj], i /∈ O (B16)
zi = tanh[hi(x) +
∑
j 6=i
Jij(x)zj]. (B17)
We solve the equations by iteration starting from random initial values for the xa, yi(i ∈
O), zi, and the χ
a
i .
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FIG. 2. The sign and disease probabilities in the homogenuous fully-connected models vs the
fraction of observed signs NO/NS . We assume that all the observed signs are positive. The prior
disease probabilities and the leak sign probabilities are P0(Da = 1) = P (Si = +1|0) = 0.001.
Panels (a),(b) show the probability of observing a positive sign P (S = 1) and the probability of
having a disease P (D = 1) for the D1S1 and D2S1 models (Kaij = K
ab
ij = 0). Panels (c),(d) display
the above probabilities for the D1S2 and D2S2 models (Kaij = K
ab
ij = 1).
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FIG. 3. Comparing the accuracy (true positive plus true negative) of the diagnosis (panels a,b,c)
and the relative gaps (panels d,e,f) in the disease probabiltiies (sorted by magnitude) ∆p12 =
(P1−P2)/P1 and ∆p23 = (P2−P3)/P2 for the D1S1 and D2S1 models using an exhastive inference
algorithm. We consider the cases in which only one or two diseases are present (|D| = 1, 2). The
prior disease probabilities are chosen such that NDP0(Da = 1) = |D|. The model parameters are
obtained from the exponential true model for different values of β. The filled circles in the top
panels show the results after a simulation process of T = NO/2 steps, where NO is the initial
number of the observed signs with known true values. For the model structure we take a fully-
connected graph of ND = 5, NS = 20 variables with Ma = 5,Mab = 10 interaction factors, and
connectivities ka = kab = 20. The data are results of 2000 independent realizations of the problem.
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FIG. 4. Comparing the convergence probability (panels a,b,c) and accuracy (true positive plus true
negative) of the diagnosis with and without extrapolation (panels d,e,f) for the D1S1 and D2S1
models using the MF approximation. We consider the cases in which only one or two diseases are
present (|D| = 1, 2). The prior disease probabilities are chosen such thatNDP0(Da = 1) = |D|. The
model parameters are obtained from the exponential true model. The filled circles show the results
after a simulation process of T = NO/2 steps, where NO is the initial number of the observed signs
with known true values. For the model structure we take a random graph of ND = 50, NS = 500
variables with Ma = 50,Mab = 500 interaction factors, and connectivities ka = kab = 400. The
data are results from at least 100 independent realizations of the problem.
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FIG. 5. The improvment in the statistics of the first right and wrong diagnosis times (TR, TW )
after maximizing the objective function E [O(T )] with the D1S1 and D2S1 models using the MF
approximation. The algorithm starts from a random sequence of T = NO/2 observations, where
NO is the initial number of the observed signs with known true values. Panels (a,b,c) show the
probabilities P (∆TR,W < 0) of decreasing the corresponding times by the algorithm. Panels (d,e,f)
show the average values ∆TR;W of the changes in the corresponding times by the algorithm. We
consider the cases in which only one or two diseases are present (|D| = 1, 2). The prior disease
probabilities are chosen such that NDP0(Da = 1) = |D|. The model parameters are obtained from
the exponential true model. For the model structure we take a random graph of ND = 50, NS = 500
variables with Ma = 50,Mab = 500 interaction factors, and connectivities ka = kab = 400. The
data are results of at lesat 100 independent realizations of the problem.
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FIG. 6. Comparing the accuracy of the diagnosis with and without extrapolation for the D2S1
model using the MF approximation. We consider the cases in which only two diseases are present
(|D| = 2). The prior disease probabilities are chosen such that NDP0(Da = 1) = |D|. The model
parameters are obtained from the exponential true model. The filled circles show the results after
a simulation process of T = NO/2 steps, where NO is the initial number of the observed signs
with known true values. For the model structure we take a random graph of ND = 50, NS = 500
variables with Ma = 50,Mab = 500 interaction factors, and connectivities ka = kab = 400. The
data are results of at lesat 100 independent realizations of the problem.
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FIG. 7. The free energy landscape as a function of the sign and disease probabilities in the
homogenuous fully-connected D2S1 model. We assume that all the observed signs are positive.
Here P (D = 1) = x, P (S = +1) = (1 + y)/2, and no = NO/NS . The prior disease probabilities
and the leak sign probabilities are P0(Da = 1) = P (Si = +1|0) = 0.001.
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